Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

MVP treatment is effective and safe for recurrent breast cancer.

The treatment is safe and shows promise for metastatic breast cancer.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

A new method effectively predicts estrogen-related health effects for early screening.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The drug combination was safe and showed promise in treating advanced tumors.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Certain genes can predict how well breast cancer patients respond to chemotherapy.